- 12.02.2020

Weimer pharma gmbh

weimer pharma gmbhshowcatalog.ru is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, jobs, events, and service company. Products and Services · Clinical Trials and Development Services · Contract Manufacturing · Drug Delivery Systems · Packaging Machines and Labelling · Site.

Weimer Pharma is one of a small group of companies worldwide providing cartridge filling services, serving more than 80 pharmaceutical companies.

Weimer pharma gmbh

The passive safety syringe is a fully weimer pharma gmbh and fully passive safety sharp. The cartridge can also be inserted into the intravenous shuttle to administer the medication through any standard intravenous line.

Weimer pharma gmbh

Finally, the cartridge can be enclosed in weimer pharma gmbh weimer pharma gmbh vial, allowing the medication to be accessed for injection in smaller doses from the same cartridge.

The combined features weimer pharma gmbh the platform provide greater weimer pharma gmbh to the patient, primarily by helping to ensure weimer pharma gmbh dosing, as well as increasing clinician and community safety by preventing needlestick injuries and the potential spread of bloodborne pathogens.


Weimer pharma gmbh Company licenses, develops weimer pharma weimer pharma gmbh manufactures transformational technologies marketed through its global medical device source. For 70 years Weimer Pharma has been a renowned contract manufacturer and developer for pharmaceutical companies in Europe weimer pharma gmbh beyond.

Weimer pharma gmbh

Weimer pharma gmbh company is a partner for customers in all aspects of pharmaceutical manufacturing, ranging from development, to regulatory affairs, manufacturing, packaging, logistics and quality control. The company also offers weimer pharma gmbh wide range of production options and outsourcing solutions for solid and liquid doses.

Weimer pharma gmbh

Actual results and the timing of events could differ materially from those anticipated in these forward- looking statements as a result of a number of factors, including our ability to identify and acquire medical safety device safety technologies with product development potential; our ability to successfully develop and bring products to market, including obtaining regulatory approvals; our ability to successfully increase sales of our products; our ability to obtain additional financing on satisfactory terms; weimer pharma gmbh ability to attract and retain qualified employees; and governmental regulation associated with the medical safety products industry.

Words such as "anticipate," "estimate," "plan," "continuing," "ongoing," "expect," "believe," "intend," "may," "will," "should," "could," and similar expressions are weimer pharma gmbh to identify forward-looking statements.

We refer you to the more detailed discussion of risks and uncertainties under "Risk Factors" in our Annual Report on Form K and our other reports on file weimer pharma gmbh the Securities and Exchange Commission.

Weimer pharma gmbh

8 мысли “Weimer pharma gmbh

  1. Completely I share your opinion. In it something is and it is excellent idea. It is ready to support you.


Your e-mail will not be published. Required fields are marked *